Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC selected retail price reductions will begin in September.

This article was originally published in The Tan Sheet

Executive Summary

GNC SELECTED RETAIL PRICE REDUCTIONS PLANNED FOR SEPTEMBER START-UP in a strategy addressing price-oriented competition from mass market and discount outlets. The dietary supplement specialty retailer will begin discounting a rotating collection of eight to 12 basic vitamin products, including vitamins B, C and E, by up to 40% in each of its 3,700-plus stores this fall. Periodic price reductions on the "commodity"-type products also are expected to help increase store traffic.

You may also be interested in...



GNC To Gain Broad R&D Pipeline From New Owner Royal Numico

The acquisition of General Nutrition Companies by the Dutch conglomerate Royal Numico will give the Pittsburgh-based supplement retailer an extensive R&D foundation on which to develop original nutritional products. The agreement was announced July 5.

GNC To Gain Broad R&D Pipeline From New Owner Royal Numico

The acquisition of General Nutrition Companies by the Dutch conglomerate Royal Numico will give the Pittsburgh-based supplement retailer an extensive R&D foundation on which to develop original nutritional products. The agreement was announced July 5.

GNC To Gain Broad R&D Pipeline From New Owner Royal Numico

The acquisition of General Nutrition Companies by the Dutch conglomerate Royal Numico will give the Pittsburgh-based supplement retailer an extensive R&D foundation on which to develop original nutritional products. The agreement was announced July 5.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel